1Brenner P,Krause-Bergmann A,Van VH.Dupuytren contracture in North Germany.Epidemiological study of 500 cases[J].Unfallchirurg,2001,104:303～ 311.
2Saboeiro AP,Porkorny JJ,Shehadi SI,et al.Racial distribution of Dupuytren' s disease in Department of Veterans Affairs patients[J].Plast Reconstr Surg,2000,106:71 ～ 75.
3Kloen P.New insights in the development of Dupuyrent' s contracture:a review[J].Br J Plast Surg,1999,52:629～635.
4Magro G,Fraggetta F,Travali S,et al.Immunohistochemical expression and distribution of alpha2betal,alpha6betal,alpha5betal integrins and their extracellular ligands,type Ⅳ collagen,laminin and fibronectin in palmar fibromatosis[J].Gen Diagn Pathol,1997,143:203～ 208.
5Gudmundsson KG,Arngrimsson R,Arinbjarnarson S,et al.Tand B-lymphocyte subsets in patients with Dupuytren disease.Correlations with disease severity[J].J Hand Surg,1998,23:724～27.
6Jemec B,Grobbelaar AO,Wilson GD,et al.Is Dupuytren' s disease caused by an imbalance between proliferation and cell death[J].J Hand Surg,1999,24:511～514.
7Dave SA,Banducci DR,Graham WP,et al.Differences in alpha smooth muscle actin expression between fibroblasts derived from Dupuytren' s nodules or cords[J].Exp Mol Pathol,2001,71:147～155.
8Bisson MA,Mudera V,McGrouther DA,et al.The contractile properties and responses to tensional loading of Dupuytren's disease-derived fibroblasts are altered:a cause of the contracture?[J].Plast Reconstr Surg,2004,113:611～621.
